New Vaccine Shows 99 Percent Antibody Development
A vaccine tested on approximately 4,000 volunteers aged 18 to 65 in the United States showed that nearly 99% of participants developed antibodies against the virus. Common side effects reported included mild symptoms such as headache, body aches, fatigue, and fever.
Topics
Developing
- 891d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 891d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 891d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 891d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
CBN São Paulo
“A vacina foi testada em cerca de 4 mil voluntários entre 18 e 65 anos nos Estados Unidos. Os resultados apontam que quase 99% dos participantes desenvolveram anticorpos contra o vírus.”
Tokyo FM
“New Vaccine Shows 99 Percent Antibody Development”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade